May 25, 2023
Genome Medical Supporting Beam Therapeutics on its Sickle Cell Disease Clinical Trial
South San Francisco – May 25, 2023 – Genome Medical, the leading telehealth provider of genetic services and solutions, is teaming up with Beam Therapeutics Inc. to provide access to genetic counseling for participants in Beam’s BEACON clinical trial evaluating BEAM-101 as a potential treatment for sickle cell disease…
Read More